Drug developed by NCDDG-OI to enter clinical trials. National Cooperative Drug Discovery Group Program for Opportunistic Infections.
Doepel
L K
LK
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000890:Anti-Infective Agents / Q000138:chemical synthesis / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D015195:Drug Design; D006801:Humans; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy*
D000890:Anti-Infective Agents